NPPA fixes retail prices for 29 formulations
The prices fixed for each unit of the formulation are based on the strength of the formulation. Further, these prices are fixed for specified manufacturers & marketing companies. The retail price for a pack of these formulations will be determined by the manufacturers based on the retail price fixed for the unit of the formulation. Manufacturers are required to issue a price list in Form–V to NPPA as per the provisions of DPCO, 2013. If retail prices fixed by this Order for any of the specified formulations are not complied with, the concerned manufacturer/marketing company will be liable to deposit the overcharged amount along with the interest thereon.
The Central Government expands the purview of CSR contributions
The Amendment to Schedule VII of the Companies Act, 2013 has enhanced the list of bodies to which companies are permitted to make contributions, for the purposes of CSR. Prior to this amendment, the list did not include the Department of Biotechnology (DBT), Ministry of AYUSH or the Department of Pharmaceuticals. Furthermore, the amendment now also permits contributions to R&D projects, in the field of science, technology, engineering and medicine, funded by the Central/ State Government/ any agency thereof/ by PSUs. This provision was also absent prior to the present amendment. Therefore, by virtue of this amendment, companies can undertake contribution to these additional bodies as well as specified R&D projects as part of their CSR activities.
Maharashtra PCB to provide services under the Maharashtra Right to Public Services Act, 2015.
The detailed procedure regarding submission of online application under EWaste Management Rules, 2016 shall be obtained within 120days from receipt of application complete in all respect.
IRDAI issues dividend criteria for equity investment under approved investment.
IRDAI permitted Insurers to classify investments in Preference Shares and Equity Shares as a part of “Approved Investment” if such Shares have paid a dividend for at least 2 years out of 3 consecutive years immediately preceding.
The Companies (Corporate Social Responsibility Policy) Amendment Rules, 2020.
Any company engaged in research and development (R&D) activity of new vaccine, drugs and medical devices in their normal course of business may undertake research and development activity of new vaccine, drugs and medical devices related to COVID-19 for financial years 2020-21, 2021-22 and 2022-23 which falls under the CSR policy.
The government of Puducherry formulates a self-certification cum online common inspection scheme for shops and establishments.
The scheme provides for transparency in the implementation of labour laws to effectively protect the interest of employer/employee and also brings in transparency in the inspection procedure by introducing computerized system of risk assessment based inspection.
